Coccidioidomycosis

Nathan W. Stockamp, George Richard Thompson

Research output: Contribution to journalReview article

55 Citations (Scopus)

Abstract

Coccidioides immitis and C posadasii are pathogenic dimorphic fungi responsible for causing coccidioidomycosis in the Southwestern United States and Central and South America. Antifungal therapy is beneficial and entails careful periodic assessment with therapies ranging from none or short courses of therapy to prolonged antifungal therapy. Factors that influence the decision to treat are the duration or severity of infection, radiographic findings, anticomplementary titers, presence of underlying immunosuppression, and comorbidities. Cure for disseminated infection is infrequent with current treatment regimens. This review summarizes the management guidelines for various disease manifestations and reviews data on challenging cases with newer agents.

Original languageEnglish (US)
Pages (from-to)229-246
Number of pages18
JournalInfectious Disease Clinics of North America
Volume30
Issue number1
DOIs
StatePublished - Mar 1 2016

Fingerprint

Coccidioidomycosis
Southwestern United States
Coccidioides
Therapeutics
Central America
South America
Infection
Immunosuppression
Comorbidity
Fungi
Guidelines

Keywords

  • Coccidioides
  • Coccidioidomycosis
  • Epidemiology
  • Meningitis
  • Primary infection
  • Treatment

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Coccidioidomycosis. / Stockamp, Nathan W.; Thompson, George Richard.

In: Infectious Disease Clinics of North America, Vol. 30, No. 1, 01.03.2016, p. 229-246.

Research output: Contribution to journalReview article

Stockamp, Nathan W. ; Thompson, George Richard. / Coccidioidomycosis. In: Infectious Disease Clinics of North America. 2016 ; Vol. 30, No. 1. pp. 229-246.
@article{1fffc9160bc24db4bd55233a5a4e396a,
title = "Coccidioidomycosis",
abstract = "Coccidioides immitis and C posadasii are pathogenic dimorphic fungi responsible for causing coccidioidomycosis in the Southwestern United States and Central and South America. Antifungal therapy is beneficial and entails careful periodic assessment with therapies ranging from none or short courses of therapy to prolonged antifungal therapy. Factors that influence the decision to treat are the duration or severity of infection, radiographic findings, anticomplementary titers, presence of underlying immunosuppression, and comorbidities. Cure for disseminated infection is infrequent with current treatment regimens. This review summarizes the management guidelines for various disease manifestations and reviews data on challenging cases with newer agents.",
keywords = "Coccidioides, Coccidioidomycosis, Epidemiology, Meningitis, Primary infection, Treatment",
author = "Stockamp, {Nathan W.} and Thompson, {George Richard}",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.idc.2015.10.008",
language = "English (US)",
volume = "30",
pages = "229--246",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Coccidioidomycosis

AU - Stockamp, Nathan W.

AU - Thompson, George Richard

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Coccidioides immitis and C posadasii are pathogenic dimorphic fungi responsible for causing coccidioidomycosis in the Southwestern United States and Central and South America. Antifungal therapy is beneficial and entails careful periodic assessment with therapies ranging from none or short courses of therapy to prolonged antifungal therapy. Factors that influence the decision to treat are the duration or severity of infection, radiographic findings, anticomplementary titers, presence of underlying immunosuppression, and comorbidities. Cure for disseminated infection is infrequent with current treatment regimens. This review summarizes the management guidelines for various disease manifestations and reviews data on challenging cases with newer agents.

AB - Coccidioides immitis and C posadasii are pathogenic dimorphic fungi responsible for causing coccidioidomycosis in the Southwestern United States and Central and South America. Antifungal therapy is beneficial and entails careful periodic assessment with therapies ranging from none or short courses of therapy to prolonged antifungal therapy. Factors that influence the decision to treat are the duration or severity of infection, radiographic findings, anticomplementary titers, presence of underlying immunosuppression, and comorbidities. Cure for disseminated infection is infrequent with current treatment regimens. This review summarizes the management guidelines for various disease manifestations and reviews data on challenging cases with newer agents.

KW - Coccidioides

KW - Coccidioidomycosis

KW - Epidemiology

KW - Meningitis

KW - Primary infection

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84958104051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958104051&partnerID=8YFLogxK

U2 - 10.1016/j.idc.2015.10.008

DO - 10.1016/j.idc.2015.10.008

M3 - Review article

C2 - 26739609

AN - SCOPUS:84958104051

VL - 30

SP - 229

EP - 246

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

SN - 0891-5520

IS - 1

ER -